EC Gynaecology

Guest Editorial Volume 12 Issue 10 - 2023

Vulvodynia Management and Therapy

Luana Malagutti Machado1 and Samantha Condé Rocha Rangel2*

1Urogynecology Physiotherapist, Clínica Condé, Brazil

2Department of Urogynecology, Unicamp University, Women´s Health at Hospital Pró Cardiaco, Clínica Condé, Brazil

*Corresponding Author: Samantha Condé Rocha Rangel, Department of Urogynecology, Unicamp University, Women´s Health at Hospital Pró Cardiaco, Clínica Condé, Brazil.
Received: July 12, 2023; Published: September 28, 2023




Vulvodynia, as defined by the International Society for the Study of Vulvovaginal Disease, is characterized by persistent vulvar pain lasting more than three months without a clearly identifiable cause. It can be influenced by various factors, including psychological, genetic, inflammatory, or neuroproliferative elements. The symptoms of vulvodynia can significantly impact a woman's life, potentially leading to psychological disorders. Our goal is to present treatment options that include urogynecological physiotherapy, electrotherapy, and pharmacological management of primary chronic pain. In conclusion, vulvodynia likely results from a combination of factors and can be controlled or alleviated through a multidisciplinary approach tailored to the specific type and severity of the condition.

 Keywords: Vulvovaginal Disease; Vulvodynia; Vulvar Pain; Urogynecological Physiotherapy; Electrotherapy

  1. Moyal-Barracco M and Lynch PJ. “ISSVD Terminology and classification of vulvodynia: a historical perspective”. The Journal of Reproductive Medicine10 (2003): 772-777.
  2. Vieira-Baptista P., et al. “Prevalence of vulvodynia and risk factors for the condition in Portugal”. International Journal of Gynecology and Obstetrics3 (2014): 283-287.
  3. De Andres J., et al. “Vulvodynia-an evidence-based literature review and proposed treatment algorithm”. Pain Practice2 (2015): 204-236.
  4. Nguyen RH., et al. “Urogenital infections in relation to the occurrence of vulvodynia”. The Journal of Reproductive Medicine 54 (2009): 385-392.
  5. Reed BD., et al. “Relationship between vulvodynia and chronic comorbid pain conditions”. Obstetrics and Gynecology 120 (2012): 145-151.
  6. Harlow BL., et al. “Influence of oral contraceptive use on the risk of adult- onset vulvodynia”. The Journal of Reproductive Medicine 53 (2008): 102-110.
  7. Zhang Z., et al. “Altered central sensitization in subgroups of women with vulvodynia”. The Clinical Journal of Pain9 (2011): 755-763.
  8. Goldstein AT., et al. “Vulvodynia: Assessment and Treatment”. Journal of Sexual Medicine 13 (2016): 572-590.
  9. Bornstein J., et al. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain (2019).
  10. Hatmann EH and Nelson C. “The Perceived Effectiveness of Physical Therapy Treatment on Women Complaining of Vulvar Pain and Diagnosed with Either Vulvar Vestibulitis Syndrome or Dysesthetic Vulvodynia”. Journal of the Section on Women’s Health 25 (2001): 13-18.
  11. Glazer H and Ledger WJ. “Clinical Management of Vulvodynia”. Reviews in Obstetrics and Gynecology 2 (2002): 83-90.
  12. Conde Samantha and Davila W. “Fisioterapia uroginecológica”. In: Silvio Silva Fernandes. (Org.). Ginecologia: Clínica e Cirúrgica. 1st Rio de Janeiro: Rubio (2018): 213-217.

Luana Malagutti Machado and Samantha Condé Rocha Rangel. Vulvodynia Management and Therapy. EC Gynaecology 12.10 (2023): 01-04.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net